FOURTEEN DAY SEQUENTIAL THERAPY CONTAINING RABEPRAZOLE VERSUS 10 AND 14 DAY CONCOMITANT THERAPY IN THE FIRST LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: AN OPEN LABEL, SINGLE CENTER, RANDOMIZED CLINICAL TRIAL

Conference
UEG Week 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing